Therapeutic Asset Ratings
766 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
177lu-r11228
Hormone Receptor-Positive Breast Cancer
Radionetics Oncology
P1
CC
(43)
[ 18f]3f4ap
Demyelinating Disease
Yale University
P1
CC
(43)
[ 18f]3f4ap
Multiple Sclerosis
Yale University
P1
CC
(43)
[ 18f]3f4ap
Spinal Cord Injury
Yale University
P1
CC
(43)
[ 18f]3f4ap
Radiculopathy
Yale University
P1
CC
(43)
[18f]flortaucipir
Alzheimer Disease
Eli Radiopharma
P1
CC
(43)
18f-trx
Nonpapillary Renal Cell Carcinoma
Rahul Aggarwal
P1
CC
(43)
18f-trx
Renal Cell Carcinoma
Rahul Aggarwal
P1
CC
(43)
18f-trx
Prostate Cancer
Rahul Aggarwal
P1
CC
(43)
²¹²pb-dotam-grpr1
Castration-Resistant Prostate Carcinoma
Orano Med Theranostics, SAS
P1
CC
(43)
[212pb]vmt-alpha-net
Esthesioneuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Digestive System Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Head And Neck Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Kidney Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Olfactory Neuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Pheochromocytoma-Paraganglioma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Somatostatin Receptor Positive
National Cancer Institute (NCI)
P1
CC
(43)
225ac-abd147
Pulmonary Large Cell Neuroendocrine Carcinoma
Abdera Therapeutics Inc.
P1
CC
(43)
225ac-abd147
Small Cell Lung Carcinoma
Abdera Therapeutics Inc.
P1
CC
(43)
[225Ac]Ac-AKY-1189
Cervical Adenocarcinoma
Aktis Oncology, Inc.
P1
CC
(43)
[225Ac]Ac-AKY-1189
Hormone Receptor-Positive Breast Cancer
Aktis Oncology, Inc.
P1
CC
(43)
225ac-etn029
Gastroenteropancreatic Neuroendocrine Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
225ac-etn029
Pulmonary Large Cell Neuroendocrine Carcinoma
Novartis Pharmaceuticals
P1
CC
(43)
Showing 251 to 275 of 766 assets
Previous
Page 11 of 31
Next
